← Back to headlines
Repligen to Acquire BioLife Solutions for $1.5 Billion
Repligen announced its intention to acquire BioLife Solutions in a deal valued at $1.5 billion. This strategic acquisition aims to expand Repligen's presence and capabilities within the cell therapy market.
22 Jul, 19:03 — 22 Jul, 19:03
Sources
Showing 1 of 1 sources
